There are currently over 463 million adults who have diabetes today, and that number is expected to reach over 700 million by 2045.
Moving forward, MicroTech Medical plans to use the fresh funds to expand its existing product line-up to new markets, as well as develop new technologies that can be commercialised.
The company is also looking to develop a closed-loop artificial pancreas, enhance its cloud-based blood glucose data management system, invest in research and development, and grow its global sales team.
Have a company of your own? Create a company profile today and easily find customers, raise funds, or hire talent.